中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2014年
11期
1605-1610,1611
,共7页
杨烨%颜晓静%毕蕾%陈姗姗%朱晶晶%陈卫平
楊燁%顏曉靜%畢蕾%陳姍姍%硃晶晶%陳衛平
양엽%안효정%필뢰%진산산%주정정%진위평
正交设计%丹参%人参%乳腺癌%组分配伍%高内涵
正交設計%丹參%人參%乳腺癌%組分配伍%高內涵
정교설계%단삼%인삼%유선암%조분배오%고내함
orthogonal design%Salvia Miltiorrhiza%Panax Ginseng%brest cancer%components combina-tion%high content screening(HCS)
目的:优选丹参-人参活性组分抗乳腺癌的最佳配伍,初步研究其作用机制。方法采用正交设计,以人乳腺癌细胞MCF-7为研究对象,人乳腺正常上皮细胞MCF-10A作为对照,应用CCK-8法,以细胞生长抑制率为指标优选丹参-人参活性组分的最佳配伍;结合实时细胞分析技术验证最佳配伍对细胞的增殖抑制作用;采用高内涵细胞分析技术检测最佳配伍对细胞凋亡的影响。结果优选出丹参-人参抗乳腺癌的最佳配伍为:丹参总酚酸、人参总皂苷和人参多糖,其配比是5、10、5 mg·L-1;实时细胞分析技术检测结果表明,最佳配伍对乳腺癌细胞MCF-7增殖抑制作用明显,对正常乳腺细胞MCF-10A的增殖抑制作用不明显;高内涵荧光细胞分析检测最佳配伍的Hoechst、Annexin V、PI染色荧光,与对照组相比,诱导凋亡作用对于MCF-7细胞差异有显著性(P<0.01),对于MCF-10A细胞差异无显著性(P>0.05)。结论丹参-人参活性组分的最佳配伍对乳腺癌MCF-7细胞有较强的增殖抑制和诱导凋亡作用,而对正常乳腺MCF-10A细胞无明显影响,具有选择性抗MCF-7乳腺癌的作用。
目的:優選丹參-人參活性組分抗乳腺癌的最佳配伍,初步研究其作用機製。方法採用正交設計,以人乳腺癌細胞MCF-7為研究對象,人乳腺正常上皮細胞MCF-10A作為對照,應用CCK-8法,以細胞生長抑製率為指標優選丹參-人參活性組分的最佳配伍;結閤實時細胞分析技術驗證最佳配伍對細胞的增殖抑製作用;採用高內涵細胞分析技術檢測最佳配伍對細胞凋亡的影響。結果優選齣丹參-人參抗乳腺癌的最佳配伍為:丹參總酚痠、人參總皂苷和人參多糖,其配比是5、10、5 mg·L-1;實時細胞分析技術檢測結果錶明,最佳配伍對乳腺癌細胞MCF-7增殖抑製作用明顯,對正常乳腺細胞MCF-10A的增殖抑製作用不明顯;高內涵熒光細胞分析檢測最佳配伍的Hoechst、Annexin V、PI染色熒光,與對照組相比,誘導凋亡作用對于MCF-7細胞差異有顯著性(P<0.01),對于MCF-10A細胞差異無顯著性(P>0.05)。結論丹參-人參活性組分的最佳配伍對乳腺癌MCF-7細胞有較彊的增殖抑製和誘導凋亡作用,而對正常乳腺MCF-10A細胞無明顯影響,具有選擇性抗MCF-7乳腺癌的作用。
목적:우선단삼-인삼활성조분항유선암적최가배오,초보연구기작용궤제。방법채용정교설계,이인유선암세포MCF-7위연구대상,인유선정상상피세포MCF-10A작위대조,응용CCK-8법,이세포생장억제솔위지표우선단삼-인삼활성조분적최가배오;결합실시세포분석기술험증최가배오대세포적증식억제작용;채용고내함세포분석기술검측최가배오대세포조망적영향。결과우선출단삼-인삼항유선암적최가배오위:단삼총분산、인삼총조감화인삼다당,기배비시5、10、5 mg·L-1;실시세포분석기술검측결과표명,최가배오대유선암세포MCF-7증식억제작용명현,대정상유선세포MCF-10A적증식억제작용불명현;고내함형광세포분석검측최가배오적Hoechst、Annexin V、PI염색형광,여대조조상비,유도조망작용대우MCF-7세포차이유현저성(P<0.01),대우MCF-10A세포차이무현저성(P>0.05)。결론단삼-인삼활성조분적최가배오대유선암MCF-7세포유교강적증식억제화유도조망작용,이대정상유선MCF-10A세포무명현영향,구유선택성항MCF-7유선암적작용。
Aim To optimize the most effective compo-nent formula from the active ingredients of Salvia Milti-orrhiza and Panax Ginseng through the orthogonal de-sign method to resist breast cancer, and to reveal its antitumor mechanism in MCF-7 cells. Methods The human breast cancer cells MCF-7 were employed as the research object and the normal breast epithelial cells MCF-10A were used as control,optimizing the most ef-fective component formula from the active ingredients of Salvia Miltiorrhiza and Panax Ginseng by using CCK-8 assay and orthogonal design method; real-time cell a-nalysis was used to monitor the best combination formu-la on cell proliferation, and high content screening was used to detect the best combination drug on cell apop-tosis. Results The best combination of the salvianolic acids, saponins of Panax Ginseng and ginseng polysac-charides that were screened out were 5 , 10 , 5 mg · L-1 . Compared with control group, the treatment group had effective response inhibiting the proliferation on MCF-7 cells, but those effects were weaker on MCF-10A cells through real-time cell analysis. Ho-echst, Annexin V, PI staining fluorescence showed no significant difference ( P >0. 05 ) on MCF-10 A cells compared with the control group,but there was signifi-cant difference ( P <0. 01 ) on MCF-7 cells by HCS. Conclusions The most effective component formula from the active ingredients of Salvia Miltiorrhiza and Panax Ginseng have a strong inhibition of proliferation and induction of apoptosis to resist breast cancer with selection, and there is no significant difference in MCF-10A cells.